Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Pract Radiat Oncol. 2016 May 20;6(6):e291–e298. doi: 10.1016/j.prro.2016.05.004

Figure 1.

Figure 1

Depictions of protocol acceptable and unacceptable doses to spinal cord and a second serial organ (bowel) that both overlap with a PTV for a patient intended to be treated on NRG-XXX.